Lately, individual states have become more interested in the ramifications of life sciences research and more assertive in forming policies that affect it (see "The State of Science Funding," The Scientist, March 2006). Both large and small states are now spending billions of dollars to support bioscience research and infrastructure (for examples, see www.battelle.org/news/06/default.stm). This "new federalism" in life sciences policy is directly linked to the combination of powerful economic incentives, and slowed or stalled federal initiatives related to healthcare and funding for R&D.
Clearly, state and federal governments must work together to develop coherent policies that simultaneously use scarce funding resources wisely, promote better health outcomes, and encourage economic development. Here's how:
Research infrastructure has long been supported by a combination of federal, state, local, and private concerns. However, conflict between state and federal governments may be on the rise as states begin to compete for life sciences talent ...
